Tyrosine Kinase Inhibitors Outperform Immune Checkpoint Inhibitors in Bone-Predominant Metastatic Renal Cell Carcinoma: A Multicenter Real-World Analysis.
Saved in:
| Title: | Tyrosine Kinase Inhibitors Outperform Immune Checkpoint Inhibitors in Bone-Predominant Metastatic Renal Cell Carcinoma: A Multicenter Real-World Analysis. |
|---|---|
| Authors: | Meng L; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA., Psutka SP; Department of Urology, The University of Washington and Fred Hutchinson Cancer Center, Seattle, WA 98195, USA., Gheeya J; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA., Li M; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA., Noonavath M; Department of Urology, The University of Washington and Fred Hutchinson Cancer Center, Seattle, WA 98195, USA., Orcutt D; Department of Urology, The University of Washington and Fred Hutchinson Cancer Center, Seattle, WA 98195, USA., Gross E; Department of Urology, The University of Washington and Fred Hutchinson Cancer Center, Seattle, WA 98195, USA., Collier KA; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA., Mortazavi A; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA., Folefac E; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA., Monk P; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA., Yang Y; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA. |
| Source: | Journal of Cancer [J Cancer] 2025 Sep 22; Vol. 16 (14), pp. 4047-4054. Date of Electronic Publication: 2025 Sep 22 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101535920 Publication Model: eCollection Cited Medium: Print ISSN: 1837-9664 (Print) Linking ISSN: 18379664 NLM ISO Abbreviation: J Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41210691 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Tyrosine Kinase Inhibitors Outperform Immune Checkpoint Inhibitors in Bone-Predominant Metastatic Renal Cell Carcinoma: A Multicenter Real-World Analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Meng+L%22">Meng L</searchLink>; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.<br /><searchLink fieldCode="AU" term="%22Psutka+SP%22">Psutka SP</searchLink>; Department of Urology, The University of Washington and Fred Hutchinson Cancer Center, Seattle, WA 98195, USA.<br /><searchLink fieldCode="AU" term="%22Gheeya+J%22">Gheeya J</searchLink>; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.<br /><searchLink fieldCode="AU" term="%22Li+M%22">Li M</searchLink>; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.<br /><searchLink fieldCode="AU" term="%22Noonavath+M%22">Noonavath M</searchLink>; Department of Urology, The University of Washington and Fred Hutchinson Cancer Center, Seattle, WA 98195, USA.<br /><searchLink fieldCode="AU" term="%22Orcutt+D%22">Orcutt D</searchLink>; Department of Urology, The University of Washington and Fred Hutchinson Cancer Center, Seattle, WA 98195, USA.<br /><searchLink fieldCode="AU" term="%22Gross+E%22">Gross E</searchLink>; Department of Urology, The University of Washington and Fred Hutchinson Cancer Center, Seattle, WA 98195, USA.<br /><searchLink fieldCode="AU" term="%22Collier+KA%22">Collier KA</searchLink>; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.<br /><searchLink fieldCode="AU" term="%22Mortazavi+A%22">Mortazavi A</searchLink>; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.<br /><searchLink fieldCode="AU" term="%22Folefac+E%22">Folefac E</searchLink>; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.<br /><searchLink fieldCode="AU" term="%22Monk+P%22">Monk P</searchLink>; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.<br /><searchLink fieldCode="AU" term="%22Yang+Y%22">Yang Y</searchLink>; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101535920%22">Journal of Cancer</searchLink> [J Cancer] 2025 Sep 22; Vol. 16 (14), pp. 4047-4054. <i>Date of Electronic Publication: </i>2025 Sep 22 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ivyspring+International+Publisher%22">Ivyspring International Publisher </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>101535920 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1837-9664 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218379664%22">18379664 </searchLink><i>NLM ISO Abbreviation: </i>J Cancer <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41210691 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.7150/jca.113258 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4047 Titles: – TitleFull: Tyrosine Kinase Inhibitors Outperform Immune Checkpoint Inhibitors in Bone-Predominant Metastatic Renal Cell Carcinoma: A Multicenter Real-World Analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Meng L – PersonEntity: Name: NameFull: Psutka SP – PersonEntity: Name: NameFull: Gheeya J – PersonEntity: Name: NameFull: Li M – PersonEntity: Name: NameFull: Noonavath M – PersonEntity: Name: NameFull: Orcutt D – PersonEntity: Name: NameFull: Gross E – PersonEntity: Name: NameFull: Collier KA – PersonEntity: Name: NameFull: Mortazavi A – PersonEntity: Name: NameFull: Folefac E – PersonEntity: Name: NameFull: Monk P – PersonEntity: Name: NameFull: Yang Y IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 09 Text: 2025 Sep 22 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 1837-9664 Numbering: – Type: volume Value: 16 – Type: issue Value: 14 Titles: – TitleFull: Journal of Cancer Type: main |
| ResultId | 1 |
